Q4 2024 Kinnevik AB Earnings Call Transcript
Key Points
- Kinnevik AB (KNEVF) has a strong cash position with a net cash of SEK10.9 billion, providing flexibility for future investments.
- The company's core companies, including Cityblock, Mews, Pleo, Spring Health, and TravelPerk, have shown significant revenue growth of 55% and improved margins in 2024.
- TravelPerk and Spring Health, two of Kinnevik's largest investments, were profitable in Q4 2024, allowing for increased growth investments.
- Kinnevik's private portfolio increased in value by SEK3 billion in Q4 2024, with a 7% rise in fair value driven by a large write-up in TravelPerk.
- The company has a disciplined capital allocation strategy, focusing on high-performing core companies and promising ventures like Enveda and Agreena.
- Cityblock's valuation faced a significant write-down due to multiple contractions in the healthcare sector, despite operational progress.
- Pleo's valuation declined by 10% due to increased OpEx investments impacting short-term margins.
- The private portfolio's valuation adjustments included a SEK450 million to SEK500 million hit due to more conservative valuations of smaller loss-making companies.
- The company faces challenges in accurately valuing Cityblock, with its valuation being significantly lower than co-investors' assessments.
- Kinnevik's core companies are refocusing on growth, which may lead to deviations from profitability in the short term, particularly for TravelPerk.
Good day, and thank you for standing by. Welcome to the Kinnevik presentation of Q4 2024. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Georgi Ganev, CEO. Please go ahead.
Thank you very much, and good morning, everyone, and welcome to the presentation of Kinnevik's results for the fourth quarter and full year of 2024. I'm Georgi Ganev, Kinnevik's CEO. And with me today is our CFO, Samuel Sjöström; and our Director of Corporate Communications, Torun Litzén.
On today's call, we will walk you through the key events during the quarter. I will also give an update on our two most recent investments in TravelPerk and Enveda. Samuel will then cover our financial position and the development of our net asset value. Finally, I will go through our priorities going into 2025 as outlined at our Capital Markets Day, and as usual, we will end with the Q&A. So let's start on page 4.
Coming out
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
